RenaissanceRe Amends 8-K, Clarifies Common Share Listing

TL;DR

**RNR just clarified its main stock listing on the NYSE.**

AI Summary

RenaissanceRe Holdings Ltd. (RNR) filed an 8-K/A on January 11, 2024, amending its previous 8-K from November 1, 2023. This amendment clarifies the securities registered under Section 12(b) of the Exchange Act, specifically listing "Common Shares, Par Value $1.00 per share" with the trading symbol RNR on the New York Stock Exchange. This matters to investors because it confirms the primary stock class traded, ensuring transparency about what shares they own or are considering buying.

Why It Matters

This filing provides clarity on the specific class of shares (Common Shares, Par Value $1.00) that are publicly traded under the RNR ticker, which is fundamental information for any investor.

Risk Assessment

Risk Level: low — This is an administrative amendment providing clarity, not indicating any new financial or operational risks.

Analyst Insight

This filing is purely administrative and provides no new financial or operational information that would warrant an immediate investment action. Investors should note the clarified common share details for record-keeping.

Key Numbers

• $1.00 — Par Value per Common Share (This is the stated par value for each common share of RenaissanceRe Holdings Ltd.)

Key Players & Entities

• RenaissanceRe Holdings Ltd. (company) — the registrant filing the 8-K/A
• RNR (company) — the trading symbol for RenaissanceRe's Common Shares
• $1.00 (dollar_amount) — the par value per share of Common Shares
• New York Stock Exchange (company) — the exchange where RNR's Common Shares are registered

FAQ

Key Financial Figures

• $1.00 — ch registered Common Shares, Par Value $1.00 per share RNR New York Stock Exchan

Filing Documents

• d705392d8ka.htm (8-K/A) — 35KB
• d705392dex231.htm (EX-23.1) — 2KB
• d705392dex232.htm (EX-23.2) — 2KB
• d705392dex991.htm (EX-99.1) — 957KB
• d705392dex992.htm (EX-99.2) — 563KB
• d705392dex993.htm (EX-99.3) — 231KB
• d705392dex994.htm (EX-99.4) — 206KB
• d705392dex995.htm (EX-99.5) — 576KB
• g705392dsp001.jpg (GRAPHIC) — 9KB
• g705392g0106020650010.jpg (GRAPHIC) — 15KB
• 0001193125-24-006640.txt ( ) — 3011KB
• rnr-20231101.xsd (EX-101.SCH) — 4KB
• rnr-20231101_def.xml (EX-101.DEF) — 14KB
• rnr-20231101_lab.xml (EX-101.LAB) — 24KB
• rnr-20231101_pre.xml (EX-101.PRE) — 15KB
• d705392d8ka_htm.xml (XML) — 9KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (a)

Financial Statements of Businesses Acquired

Financial Statements of Businesses Acquired The audited consolidated financial statements of Validus Holdings, Ltd. as at and for the years ended December 31, 2022 and 2021, are filed herewith as Exhibit 99.1 to this 8-K Amendment and are incorporated herein by reference. The unaudited consolidated financial statements of Validus Holdings, Ltd. as at September 30, 2023 and for the nine months ended September 30, 2023 and 2022, are filed herewith as Exhibit 99.2 to this 8-K Amendment and are incorporated herein by reference. The audited combined financial statements of Validus Specialty, LLC, excluding Validus Specialty Underwriting Services, Inc., an entity previously owned as a subsidiary by Validus Specialty and excluded from the Validus Acquisition ("Specialty Business of Validus Specialty, LLC") as at and for the years ended December 31, 2022 and 2021, are filed herewith as Exhibit 99.3 to this 8-K Amendment and are incorporated herein by reference. The unaudited combined financial statements of the Specialty Business of Validus Specialty, LLC as at September 30, 2023 and for the nine months ended September 30, 2022 and 2021, are filed herewith as Exhibit 99.4 to this 8-K Amendment and are incorporated herein by reference. (b) Pro Forma Financial Information. The Unaudited Pro Forma Condensed Combined Balance Sheet of the Company as at September 30, 2023 and the Unaudited Pro Forma Condensed Combined Statements of Operations of the Company for the nine months ended September 30, 2023, and the year ended December 31, 2022, which give effect to the Validus Acquisition, are filed herewith as Exhibit 99.5 to this 8-K Amendment and are incorporated herein by reference. (d) Exhibits Exhibit No. Description 23.1 Consent of PricewaterhouseCoopers Ltd. 23.2 Consent of PricewaterhouseCoopers Ltd. 99.1 Audited consolidated financial statements of Validus Holdings, Ltd. as at and for the years ended December 31, 2022 and 2021. 99.2 Unaudited consolida

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RENAISSANCERE HOLDINGS LTD. Date: By: /s/ Shannon Lowry Bender January 11, 2024 Shannon Lowry Bender Executive Vice President and Group General Counsel and Corporate Secretary

View Full Filing

View this 8-K/A filing on SEC EDGAR